FreeOx Biotech: Funding, Investors & Team (Sep 2026)
Based on the knowledge of oxidative stress and uric acid, Freeox Biotech is developing neuroprotective therapies to reduce the damage resulting from ischemia and in this way improve the recovery of the patients. Ox-01 is Uric Acid used as a medicinal product. Ox-01 has a proven effect in preventing the damage caused by reperfusion after stroke. Ox-02 Uricoline is a molecule resulting from the association of Ox-01 and Citicoline. Citicoline is an intermediate in the generation of phosphatidylcholine from choline.
FreeOx Biotech has raised $1.8M across 1 funding round on record, the most recent a Seed of $1.8M announced in Dec 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
FreeOx Biotech Company Profile and Key Stats
Latest funding round on record: Dec 2023.
FreeOx Biotech Funding Rounds
FreeOx Biotech Founders and Leadership Team
No contact details are on record for this team yet.
FreeOx Biotech Funding Compared to Other Biotechnology Startups
FreeOx Biotech's latest round of $1.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like FreeOx Biotech in Biotechnology and Barcelona
Companies Similar to FreeOx Biotech
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological…
Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic…
IMPETUX develops and markets patented technology to characterise the mechanical properties of living tissues…
Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs…
Modern medicine fails because it studies life in static environments. 60Nd revolutionizes the field with…
Devicare designs point-of-care medical devices that monitor, diagnose and treat chronic diseases. The…
Universal Diagnostics S.A. (UDX) is a company in Spain that specializes in in-vitro diagnostics. Their focus…
Phyture Biotech originated as a spin-off of the Faculty of Pharmacy at the University of Barcelona, founded…
Polimerbio offers sanitary product design and development based on biocompatible polymers, particularly…
Overture Life is a biotechnology company that specializes in developing automated technologies for assisted…
In order to cure diseases with unmet medical requirements, ARTHEx Biotech, a biotech business that was spun…
FreeOx Biotech Funding FAQs
What does FreeOx Biotech do?
Based on the knowledge of oxidative stress and uric acid, Freeox Biotech is developing neuroprotective therapies to reduce the damage resulting from ischemia and in this way improve the recovery of the patients. Ox-01 is Uric Acid used as a medicinal product. Ox-01 has a proven effect in preventing the damage caused by reperfusion after stroke. Ox-02 Uricoline is a molecule resulting from the association of Ox-01 and Citicoline. Citicoline is an intermediate in the generation of phosphatidylcholine from choline.
How much funding has FreeOx Biotech raised?
FreeOx Biotech has raised $1.8M across 1 round on record. The most recent is a Seed of $1.8M announced in Dec 2023.
When did FreeOx Biotech last raise funding?
FreeOx Biotech's most recent funding round on record is a Seed of $1.8M, announced in Dec 2023.
Who is the CEO of FreeOx Biotech?
Carlos Lurigados is listed as CEO at FreeOx Biotech.
Where is FreeOx Biotech headquartered?
FreeOx Biotech is based in Barcelona, Catalonia, Spain.
How many employees does FreeOx Biotech have?
FreeOx Biotech is in the 1-10 employee band.
How does FreeOx Biotech's funding compare to other Biotechnology startups?
FreeOx Biotech's latest round of $1.8M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's FreeOx Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for FreeOx Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.